The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.

Saved in:
Bibliographic Details
Title: The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.
Authors: Zell T; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kött J; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zimmermann N; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ancker G; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bauer AT; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Smit DJ; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Geidel G; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gerwers JC; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Renné T; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Wohlfeil SA; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.; DKFZ Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany., Schneider SW; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gebhardt C; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Source: International journal of cancer [Int J Cancer] 2026 Apr 27. Date of Electronic Publication: 2026 Apr 27.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0215
DOI:10.1002/ijc.70523